Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Novel uricosuric agents claimed by Yamasa Shoyu

Aug. 19, 1999

Tularik describes agents for lipoprotein disorders acting via a novel mechanism

Aug. 19, 1999

Parathyroid hormone prolongs the survival of osteoblasts

Aug. 19, 1999

Kissei prepares beta3-adrenoceptor stimulants as novel antiobesity agents

Aug. 18, 1999

FDA accepts PMA for OP-1 Implant

Aug. 18, 1999

Merck's newest alphavbeta3 ligands prevent osteoclast-mediated bone resorption

Aug. 16, 1999

Triazepinone compounds from Merck KGaA act as AGE formation inhibitors

Aug. 16, 1999

Pfizer redirects zopolrestat development program

Aug. 13, 1999

Buccal insulin effective in controlling postprandial hyperglycemia

Aug. 13, 1999

Glaxo Wellcome invention describes hypolipidemic activity of novel benzothiazepines

Aug. 13, 1999

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...